Management of Temporarily Elevated Tryptase
Diagnostic Distinction
- For a temporarily elevated tryptase, the priority is to determine if it was measured during or after acute symptoms, indicating mast cell degranulation requiring anaphylaxis management, or during an asymptomatic period, requiring diagnostic evaluation for underlying mastocytosis 1
- If measured within 15 minutes to 3 hours after the onset of acute symptoms, it represents acute mast cell degranulation requiring emergency treatment for anaphylaxis 2, 3
- If measured during an asymptomatic period, it requires diagnostic evaluation for chronic mastocytosis 1
Acute Elevation Management
- Administer intramuscular epinephrine immediately in the anterolateral thigh at 0.01 mg/kg (1:1000 concentration), maximum dose 0.5 mg in adults and 0.3 mg in children 5, 1
- Repeat every 5-15 minutes if necessary 2, 3
- Provide 100% oxygen immediately 5
- Establish large-bore IV access with rapid boluses of 0.9% saline or Ringer's lactate at 5-10 mL/kg in the first 5 minutes, then boluses of 20 mL/kg as needed 6, 1
Secondary Treatment
- Antihistamines H1: diphenhydramine 50 mg IV 2, 3
- Antihistamines H2: ranitidine 50 mg IV 2, 3
- Corticosteroids: hydrocortisone 200 mg IV (adult dose) every 6 hours 2, 3
Essential Diagnostic Samples
Interpretation of Tryptase to Confirm Anaphylaxis
- Use the 20% + 2 formula: an increase in acute serum tryptase above 1.2 × baseline tryptase + 2 μg/L is considered clinically significant to confirm mast cell degranulation 7, 8
Evaluation for Elevated Baseline Tryptase
- Baseline tryptase >20 μg/L: minor criterion for systemic mastocytosis, requires mandatory bone marrow evaluation 1
- Baseline tryptase >200 μg/L: indicates high mast cell burden, requires urgent referral to hematology for advanced systemic mastocytosis or mast cell leukemia 1
Long-term Management
- For confirmed systemic mastocytosis, treatment includes antimediator therapy with antihistamines H1 and H2, leukotriene inhibitors, and cromolyn sodium 4, 5, 6
- All patients with systemic mastocytosis or elevated baseline tryptase should have two epinephrine auto-injectors available at all times, a MedicAlert identification, and education on avoiding triggers 5, 1
Surveillance and Follow-up
- Refer to allergology/immunology: all patients with suspected perioperative anaphylaxis should be fully investigated 5
- Refer to hematology: mandatory if baseline tryptase >20 μg/L or systemic mastocytosis is confirmed 4
- Annual tryptase surveillance: to evaluate disease burden in diagnosed systemic mastocytosis 4